Iñaki Robles-Vera

5PUBLICATIONS
45CO-AUTHORS
Tissue engineeringPredictive and prognostic markersInnate immunityOral implantologyHost-parasite interactions
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 13, 2026
ERC-funded proof of concept grant: targeting imidazoline 1-receptor in atherosclerosis.

Annalaura Mastrangelo, Iñaki Robles-Vera, David Sancho

|Jul 16, 2025
Imidazole propionate is a driver and therapeutic target in atherosclerosis.

Annalaura Mastrangelo, Iñaki Robles-Vera, Diego Mañanes

|May 30, 2025
cDC1s Promote Atherosclerosis via Local Immunity and Are Targetable for Therapy.

Miguel Galán, Laura Fernández-Méndez, Vanessa Núñez

|Mar 10, 2025
Evolution in the Peri-Implant Oral Microbiome and Their Relationship to Long-Term Marginal Bone Loss: A Randomized Clinical Study.

Pablo Galindo-Moreno, Lourdes Gutierrez-Garrido, Juan Duarte

|Dec 29, 2019
Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects.

Iñaki Robles-Vera, Marta Toral, Néstor de la Visitación

Pageof 1